
|Articles|June 15, 2011
Julian Upton
<>
Advertisement
Julian Upton serves as European Editor for Pharm Exec and as Editor of its digital sister publication, Pharm Exec Global Digest. Julian first joined Advanstar Communications in 1998 and has worked in various editorial capacities for the company. Outside Advanstar, he has edited business magazines on topics ranging from healthcare to finance and defence.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Novartis Enters $12 Billion Definitive Merger Agreement to Acquire Avidity Biosciences
3
ACS Calls Obesity a Condition That Must Be Treated with Medication and Surgery
4
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
5





